HOME


HIV/AIDS HOTLINES


HIV BASICS


POSITIVE PROFILES


ASO SPOTLIGHT


RECENT ARTICLES


HOW TO PAY FOR HIV TREATMENT


ADAP CRITERIA AND FORMULARIES


ASO LISTINGS


REVIEW OF HIV MEDICATIONS


2010 HIV/AIDS FUNDRAISING ACTIVITIES & EVENTS


ABOUT HIV POSITIVE! MAGAZINE


LINKS


SUBSCRIBE


CONTACT US


ADVERTISER INFORMATION

Integrase Inhibitor

Isentress

(Raltegravir)

Manufacturer: Merck

The standard dose of Isentress is one 400 mg tablet taken twice a day. It can be taken without regard to food.

Evaluation: Isentress is a popular new drug, approved by the FDA in October, 2007. It is the first of a new class of drugs called “integrase inhibitors” which work by blocking a viral enzyme that helps HIV integrate with healthy cell DNA. Isentress is listed as a “preferred” drug, when used with Truvada, in the latest DHHS guidelines.




Combination Drugs

Protease Inhibitors

Nucleoside Reverse Transcriptase Inhibitors

Non-Nucleoside Reverse Transcriptase Inhibitors

Fusion Inhibitor

Entry Inhibitor

Integrase Inhibitor


Editor’s note: Special thanks to Lindsay Defelice, PharmD, and Maney Mazloom, PharmD, of CarePlus CVS Pharmacy at 560 Amsterdam Avenue in Atlanta, Georgia. They provided the HIV medications for photography in this issue.







Copyright 2010, Positive Health Publications, Inc.

This magazine is intended to enhance your relationship with your doctor - not replace it! Medical treatments and products should always be discussed with a licensed physician who has experience treating HIV and AIDS!

::: Made with CoffeeCup : Web Design Software & Website Hosting :::